CERO - CERO THERAPEUTICS HOLDINGS, INC.

QQQ $ 626.80 $ -5.22 (-0.83 %)

DIA $ 475.16 $ 1.01 (0.21 %)

SPY $ 680.41 $ -3.43 (-0.5 %)

TLT $ 90.62 $ 0.22 (0.24 %)

GLD $ 370.16 $ 5.07 (1.39 %)

Previous Close

$ 1.79

Open

$ 0.33

Bid

$ 0.10 x 100

Ask

$ 0.10 x 900

Day's Range

$ 0.10 - $ 0.40

52 Week Range

$ 1.72 - $ 895.40

Volume

1,091,509

Average Volume

Market Cap

523

Beta (5Y Monthly)

$ 0.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-22-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	04-15-2025	12-31-2024	10-K
4	11-19-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-17-2024	03-31-2024	10-Q
7	04-02-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-24-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-13-2022	03-31-2022	10-Q
15	03-24-2022	12-31-2021	10-K
16	11-19-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Thursday's...
10/30/2025 17:07:10

nasdaq-falls-over-1-alphabet-posts-upbeat-earnings

Nasdaq Falls Over 1%; Alphabet Posts Upbea...
10/30/2025 14:01:00

12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

D. Boral Capital Maintains Buy on CERo The...
10/30/2025 11:48:11

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

why-alphabet-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Why Alphabet Shares Are Trading Higher By ...
10/30/2025 09:38:55

Reported Earlier, CERo Therapeutics Receiv...
10/30/2025 08:28:44

D. Boral Capital Maintains Buy on CERo The...
10/22/2025 12:12:41

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Authorizes Investigators...
10/21/2025 12:19:45

Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq complianceSOUTH SAN FRANC...

D. Boral Capital Maintains Buy on CERo The...
10/13/2025 14:43:04

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

'CERo Therapeutics CEO: We're "open" to ta...
10/10/2025 18:12:38

https://www.axios.com/pro/biotech-deals/2025/10/10/cero-therapeutics-ceo-open-takeover-offers

Cero Therapeutics Has Received A Decision ...
09/26/2025 19:59:01

https://register.epo.org/application?number=EP22758100

D. Boral Capital Maintains Buy on CERo The...
09/23/2025 11:20:32

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Doses Third Patient In P...
09/22/2025 13:18:07

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional resul...

top-3-health-care-stocks-youll-regret-missing-in-q3

Top 3 Health Care Stocks You'll Regret Mis...
09/09/2025 13:12:17

D. Boral Capital Maintains Buy on CERo The...
09/09/2025 12:41:27

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Secures U.S. And Japanes...
09/09/2025 12:18:26

Additional patent granted from the Japanese patent office now results in 20 granted patents and allowed applications covering t...

12 Health Care Stocks Moving In Monday's I...
09/08/2025 17:07:17

CERo Therapeutics Has Administered Second ...
09/08/2025 12:47:05

CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo" or the "Company") an innovative cellular immunotherapy ...

D. Boral Capital Maintains Buy on CERo The...
09/05/2025 18:11:40

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Receives FDA Fast Track ...
09/05/2025 12:11:03